Share-based Payment Arrangement, Expense of CervoMed Inc. from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
CervoMed Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • CervoMed Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $291,717, a 7.6% increase year-over-year.
  • CervoMed Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1,487,610, a 21% increase year-over-year.
  • CervoMed Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1,405,722, a 245% increase from 2023.
  • CervoMed Inc. annual Share-based Payment Arrangement, Expense for 2023 was $407,632, a 22% increase from 2022.
  • CervoMed Inc. annual Share-based Payment Arrangement, Expense for 2022 was $333,835, a 63% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

CervoMed Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,487,610 $291,717 +$20,502 +7.6% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $1,467,108 $497,015 -$81,566 -14% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $1,548,674 $361,167 +$142,952 +66% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $1,405,722 $337,711 +$172,739 +105% 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q3 2024 $1,232,983 $271,215 +$162,047 +148% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $1,070,936 $578,581 +$516,329 +829% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 $554,607 $218,215 +$146,975 +206% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $407,632 $164,972 +$469,782 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q3 2023 $62,150 $109,168 +$26,784 +33% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $88,934 $62,252 -$215,878 -78% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $126,944 $71,240 -$206,891 -74% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $333,835 $304,810 -$559,118 -220% 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $892,953 $82,384 -$82,008 -50% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $974,961 $278,130 -$19,150 -6.4% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $994,111 $278,131 +$96,851 +53% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $897,260 $254,308 +$102,486 +68% 01 Oct 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
Q3 2021 $794,774 $164,392 -$115,081 -41% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $909,855 $297,280 +$183,836 +162% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $726,019 $181,280 -$10,100 -5.3% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $736,119 $151,822 +$21,665 +17% 01 Oct 2020 31 Dec 2020 10-K 18 Mar 2022 2021 FY
Q3 2020 $714,454 $279,473 +$134,152 +92% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $580,302 $113,444 -$35,636 -24% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $615,938 $191,380 +$100,176 +110% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q4 2019 $515,762 $130,157 -$119,602 -48% 01 Oct 2019 31 Dec 2019 10-K 17 Mar 2021 2020 FY
Q3 2019 $635,364 $145,321 -$182,075 -56% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $817,439 $149,080 -$170,689 -53% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 $988,128 $91,204 -$233,463 -72% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $1,221,591 $249,759 -$167,359 -40% 01 Oct 2018 31 Dec 2018 10-K 17 Mar 2020 2019 FY
Q3 2018 $1,388,950 $327,396 +$34,895 +12% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019 2019 Q3
Q2 2018 $1,354,055 $319,769 +$4,703 +1.5% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $1,349,352 $324,667 -$41,716 -11% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $1,391,068 $417,118 +$148,040 +55% 01 Oct 2017 31 Dec 2017 10-K 19 Mar 2019 2018 FY
Q3 2017 $1,243,028 $292,501 -$97,856 -25% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 $1,340,884 $315,066 -$23,096 -6.8% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018 2018 Q2
Q1 2017 $1,363,980 $366,383 -$27,088 -6.9% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $1,391,068 $269,078 +$48,892 +22% 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 $1,342,176 $390,357 +$248,949 +176% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 $1,093,227 $338,162 +$201,437 +147% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 $891,790 $393,471 +$297,615 +310% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $594,175 $220,186 -$311,629 -59% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 $905,804 $141,408 -$642,524 -82% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $1,548,328 $136,725 -$4,590 -3.2% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 $1,552,918 $95,856 -$54,029 -36% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q4 2014 $1,606,947 $531,815 01 Oct 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
Q3 2014 $783,932 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 $141,315 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015 2015 Q2
Q1 2014 $149,885 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 FY

CervoMed Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,405,722 +$998,090 +245% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
2023 $407,632 +$73,797 +22% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
2022 $333,835 -$563,425 -63% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
2021 $897,260 +$161,141 +22% 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
2020 $736,119 +$220,357 +43% 01 Jan 2020 31 Dec 2020 10-K 18 Mar 2022 2021 FY
2019 $515,762 -$705,829 -58% 01 Jan 2019 31 Dec 2019 10-K 17 Mar 2021 2020 FY
2018 $1,221,591 -$169,477 -12% 01 Jan 2018 31 Dec 2018 10-K 17 Mar 2020 2019 FY
2017 $1,391,068 $0 0% 01 Jan 2017 31 Dec 2017 10-K 19 Mar 2019 2018 FY
2016 $1,391,068 +$796,893 +134% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $594,175 -$1,012,772 -63% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
2014 $1,606,947 -$619,042 -28% 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
2013 $2,225,989 01 Jan 2013 31 Dec 2013 10-K 03 Apr 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.